Concourse Financial Group Securities’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 2082 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 3798 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 3790 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 3832 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 3847 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 3782 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 3755 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 3721 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 3645 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 3608 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 3390 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 3450 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 3401 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 3537 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 3492 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 3397 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 3331 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 3265 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 3107 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 3014 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 3056 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 2996 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 2712 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 3057 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 3033 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 2911 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 2488 |
|